Differential regulation of retinoblastoma tumor suppressor protein by G1 cyclin-dependent kinase complexes in vivo

Molecular and Cellular Biology

Volumn 21, Issue 14, 2001, Pages 4773-4784

  Ezhevsky, S A ^a   Ho, A ^a   Becker Hapak, M ^a   Davis, P K ^a   Dowdy, S F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN E; DIHYDROFOLATE REDUCTASE; HYBRID PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VIVO STUDY; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

CARRIER PROTEINS; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELLS, CULTURED; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F4 TRANSCRIPTION FACTOR; G1 PHASE; GENES, TUMOR SUPPRESSOR; HUMANS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; TETRAHYDROFOLATE DEHYDROGENASE; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 0034948814     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.14.4773-4784.2001     Document Type: Article

References (64)

1. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts
2. Retinoblastoma protein recruits histone deacetylase to repress transcription
3. Cumulative effect of phosphorylation of pRB on regulation of E2F activity
4. Requirements for cell cycle arrest by p16INK4a
5. 1 arrest after gamma-irradiation
6. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation
7. The Drosophila cyclin D-cdk4 complex promotes cellular growth
8. The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression
9. Differences in the mechanisms of growth control in contact-inhibited and serum-deprived human fibroblasts
10. Physical interaction of the retinoblastoma protein with human D cyclins
11. Cell cycle synchronization by elutriation
12. The regulation of E2F by pRB-family proteins
13. Cell cycle checkpoints: Preventing an identity crisis
14. Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence
15. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
16. Hypophosphorylation of the retinoblastoma protein by cyclin D:Cdk4/6 complexes results in active pRB
17. Dependence of cyclin E-CDK2 kinase activity on cell anchorage
18. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes
19. Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1
20. Hyperphosphorylation of the retinoblastoma gene product is determined by domains outside the simian virus 40 large-T-antigen-binding regions
21. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1
22. Rb function in cell-cycle regulation and apoptosis
23. INK4a-mediated growth suppression
24. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation
25. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
26. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity
27. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2
28. S-phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation
29. 1 phase cell cycle check point
30. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation
31. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
32. Cyclin E-induced S phase without activation of the pRb/E2F pathway
33. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
34. Retinoblastoma protein represses transcription by recruiting a histone deacetylase
35. Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells
36. D-type cyclin-dependent kinase activity in mammalian cells
37. Drosophila cdk4 is required for normal growth and is dispensable for cell cycle progression
38. 1 kinase activity for cdk6, a novel cyclin D partner
39. Control of pRB phosphorylation
40. Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation
41. E2F4 switches from p130 to p107 and pRB in response to cell cycle reentry
42. Cyclin-dependent kinases: Engines, clocks, and microprocessors
43. Kip1 mediates cell migration
44. TGF-β targeted inactivation of cyclin E: Cdk2 complexes by inhibition of Cdk2 activating kinase activity
45. HLA class I-mediated induction of cell proliferation involves cyclin E-mediated inactivation of RB function and induction of E2F activity
46. Toward an understanding of the functional complexity of the E2F and retinoblastoma families
47. Transfer of p16inka/CDKN2 gene in leukaemic cell lines inhibits cell proliferation
48. Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients
49. 1/S phase transition by expression of cyclins D1 and E with an inducible system
50. 1-to-S transition
51. The p16INK4a/CDKN2A tumor suppressor and its relatives
52. Hydroxylamine cleavage of proteins in polyacrylamide gels
53. In vivo protein transduction: Delivery of biologically active protein into the mouse
54. In vivo protein transduction: Intracellular delivery of biologically active proteins, compounds and DNA
55. Protein transduction: Unrestricted delivery into all cells?
56. Cancer cell cycles
57. CDK inhibitors: Positive and negative regulators of G1-phase progression
58. 1 cell state
59. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity
60. Distinct roles for cyclin-dependent kinases in cell cycle control
61. Killing HIV infected cells by direct transduction of an HIV protease-activated caspase-3 protein
62. Transduction of full length TAT fusion proteins directly into mammalian cells: Analysis of TCR-activation induced cell death (AID)
63. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease
64. The retinoblastoma protein and cell cycle control